CARL in the Apotheken Umschau

In the February issue Apotheken Umschau, the CARL System and its mode of operation are presented under the title “Grenzen verschieben” by means of a detailed graphic.

Zum Artikel

Current publication on the application of the CARL System at the Regensburg University Hospital

An article was published in the journal Perfusion in November 2022 presenting data from the first ten patients suffering from an out-of-hospital cardiovascular arrest who were treated by using the CARL System in Regensburg.

To the article

New press release

Dr. Thomas Kraft reinforces the management of Resuscitec GmbH

To the article

Recent Nature publication: Cellular recovery after prolonged warm ischaemia of the whole body

To the article

Presentation of the CARL System during the visit of the Minister of the Interior Thomas Strobl at the Medical Center – University of Freiburg

Interior Minister Thomas Strobl has visited the Medical Center – University of Freiburg where the CARL System was presented and its functions explained in detail.

To the article

CARL-induced changes of the serum proteome

A recent publication in the Journal of Translational Medicine in May 2022 describes significant changes in serum protein composition after resuscitation using controlled extracorporeal circulation in pigs.

To the article

Current publication on the benefit of the CARL Therapy

The Journal of Clinical Medicine recently published an article describing the benefits of adapted perfusion and defibrillation strategies in the setting of CARL Therapy.

To the article

Letter to the editor: Important factors regarding the analysis of extracorporeal blood flow in extracorporeal cardiopulmonary resuscitation.

To the article

INVITED EXPERT OPINION IN THE JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (JTCVS)

An Invited Expert Opinion has been published in the Journal of Thoracic and Cardiovascular Surgery (JTCVS) on the use of cardiac surgical techniques to improve outcomes of cardiopulmonary resuscitation after cardiovascular arrest.

For more information on CARL Therapy, please visit: Therapy (resuscitec.de)

To the article

Thanks to CARL – Larger time frame for successful resuscitation in cardiac arrest (text: German language)

The CARL Therapy developed by researchers of
The Medical Center – University of Freiburg and the mobile CARL System of Resuscitec GmbH provide a larger time window for the treatment of patients requiring resuscitation. An article published in “Ärztezeitung” in August,  2021 describes the therapeutic factors that are crucial for successful resuscitation even after prolonged cardiac arrest.

To the article >

‘Originally it was not planned to treat Covid patients at all’ (text: German language)

Interview with Prof. Dr.-Ing. Christoph Benk and Jörg Ronde, Managing Directors of Resuscitec GmbH in the VentureCapital Magazin

To the article >

New method of resuscitation: unharmed despite one-and-a-half hours of cardiac arrest (text: German language)

Just ten percent of those affected survive a cardiac arrest that happens outside a hospital – and only some of them without sequelae. A new method might change this. The ‘Neue Züricher Zeitung’ has published an article about CARL.

To the article >